Navigation Links
NASDAQ Gives Dynatronics a Second Three-Month Extension for Minimum Bid Price Compliance
Date:12/29/2008

SALT LAKE CITY, Dec. 29 /PRNewswire-FirstCall/ --Dynatronics Corporation (Nasdaq: DYNT) today announced that a second temporary grace period extension, filed by NASDAQ with the SEC, gives the company until approximately June 28, 2009, to comply with NASDAQ's $1 per share minimum bid rule.

"We are pleased that NASDAQ has further extended the timeframe for compliance in light of the current market environment," stated Kelvyn H. Cullimore Jr., chairman and president of Dynatronics. "This will give us time to realize the impact of operating improvements that are emerging in part because of our recent agreement with Vici Capital, a private operations consulting firm that is assisting Dynatronics in identifying significant changes that we can implement to improve our bottom line over the next year."

In addition, Dynatronics' newly expanded catalog released in September is positively impacting sales, generating improved margins through adjusted product pricing.

"We are also facilitating greater order flow from our domestic dealers through an adaptation of our DynaClub direct sales program. This promises to be a source of increased revenue over the coming year as dealers embrace the benefits of this program," Cullimore continued. "We believe all of these improvements, together with the more than $2 million in annual expense reductions we have previously implemented, should restore profitability and build investor confidence in owning our stock."

Dynatronics manufactures, markets and distributes advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables and rehabilitation equipment for the physical therapy, sports medicine, chiropractic, podiatry, plastic surgery, dermatology and other related medical, cosmetic and aesthetic markets. More information regarding Dynatronic
'/>"/>

SOURCE Dynatronics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. BELLUS Health announces formal notice to voluntarily delist from NASDAQ
2. Memory Pharmaceuticals Regains Compliance with NASDAQ Market Capitalization Requirement
3. Mylan Announces Move to NASDAQ Stock Market
4. DATATRAK International, Inc. Receives Notice from NASDAQ
5. BELLUS Health is Preparing to Voluntarily Delist from the NASDAQ Capital Market
6. Memory Pharmaceuticals Receives NASDAQ Decisions
7. PAREXEL International to Present at NASDAQ OMX 22nd Investor Program
8. Keryx Biopharmaceuticals Receives Nasdaq Notification
9. Accuray Receives Nasdaq Notification Related to the Late Filing of Form 10-Q
10. BELLUS Health Announces Stock Listing Transfer from NASDAQ Global Market to NASDAQ Capital Market
11. Pharmos Corporation Announces Receipt of Nasdaq Noncompliance Letter

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...her treatment prolongs life remains unclear, resea...Day News) -- New research suggests that enzyme rep...e lives of people with Fabry disease, a rare illne..., The progressive disease, linked to the lack of a... the body, can be fatal because it boosts the risk...
(Date:12/2/2009)... , PASADENA, Calif., Dec. 2 /PRNewswire-USNews...gram has received the Gold Seal of Approval from t...imary stroke center. This means Huntington will j...als throughout Los Angeles County. ,, "This i...re important, a wonderful benefit for Pasadena and...
(Date:12/2/2009)... , SAN FRANCISCO, Dec. 2 /PRNewswire-USNewswir...can babies are born contaminated with a plastics c... Congress must act immediately to protect infants ...ering bills to ban bisphenol A, or BPA, in food an...einstein of California and Rep. Edward Markey of M...
(Date:12/2/2009)... , New Directors Represent Div...Dec. 2 The membership o...w members to its Board of Directors and reappointe...s represent a wide range of healthcare stakeholder...suppliers, and public and community healthcare. ,...
(Date:12/2/2009)... ,, NEW YORK, Dec. 2 /PRNewswire/...t palliative care coordination, Advanced Illness ... hospitalizations in the last years of life as wel...heir family caregivers without increasing mortalit... published in American Journal of Managed Care (...
Breaking Medicine News(10 mins):Health News:Huntington Hospital Earns Designation as Primary Stroke Center 2Health News:Pre-Polluted Babies: Congress Must Act to Protect Infants, Moms from Toxic Plastics Chemical BPA 2Health News:National Quality Forum Members Elect Nine Directors to Board 2Health News:National Quality Forum Members Elect Nine Directors to Board 3Health News:Outpatient Palliative Care Reduces Hospitalizations, Which Impact Costs, While Improving Quality of Life for Seniors and Family Caregivers - New Study in American Journal of Managed Care 2Health News:Outpatient Palliative Care Reduces Hospitalizations, Which Impact Costs, While Improving Quality of Life for Seniors and Family Caregivers - New Study in American Journal of Managed Care 3Health News:Outpatient Palliative Care Reduces Hospitalizations, Which Impact Costs, While Improving Quality of Life for Seniors and Family Caregivers - New Study in American Journal of Managed Care 4
...ormed Swiss Pharmaceutical Roche AG to include the...known, influenza drug, Tami flu. This advice is cl...action of the drug, sparking erratic behaviors, ha...e department, "Health Canada has requested that th...
...IDS Control Organisation with support from Nationa...nal Institute of Medical Statistics (ICMR), conduc...isk populations, STI patients and Antenatal mother... among antenatal mothers has been observed to be m...
... of health, in England had proposed to set up an e...cords from hospitals.They had set aside ?12 billi...across Britain, however, are opposed to this proje.... A campaign against this move was launched last...
...rgeons lead robotically assisted laparoscopic surg...cessible places in the body. Laparoscopic surgeons...performed robotically assisted laparoscopic gastri...ly results in fewer complications, shorter recover...
...Burton of Mount Maunganui, who faced charges on 58...ion items has been found guilty .The trial lasted ...conducted by the Ministry of Health and the case w... Plenty District Health Board. Quentin Wilso...
...ason brings out the urge to bake in even the most ...e kid suddenly begins baking up a storm after retu...cooking or preoccupation with food may signal an e...aid Theresa Fassihi, PhD, a psychologist with the ...
Other Medicine News:Health News:Survey Reveals Rejection of NHS Database Scheme 2Health News:North Texas Surgeons Lead Robotically Assisted Laparoscopic Surgeries. 2Health News:Holiday Baking Frenzy May Mask Eating Disorder in College Kids 2Health News:Holiday Baking Frenzy May Mask Eating Disorder in College Kids 3
(Date:12/2/2009)... 2 Adults are more likely to los...adults 65 and over, the odds of losing vision are ... prostate cancer are one in six and odds of a woma...n loss threatens the overall health of aging adult...nd inability to complete daily tasks. ,, Vision...
(Date:12/2/2009)... 2 Amsterdam Molecular,T... of human gene therapy,announced today a number o...en appointed Chief Financial Officer, effective De...ctor Process Development & Manufacturing, will...ject Management, also,effective December 1. These ...
(Date:12/1/2009)...1 Reportlinker.com announces that ...atalogue: ,, Insulin Pumps (External) - A Worl...m/p0164247/Insulin-Pumps-External---A-World-Market...tinuous Subcutaneous Insulin Infusion (CSII), prov... other forms of treatment. Insulin pump is a pager...
Breaking Medicine Technology:Risk of Vision Loss in Aging Adults is Greater Than Risk of Breast or Prostate Cancer 2AMT Announces Management Changes in Light of Refocused Strategy 2AMT Announces Management Changes in Light of Refocused Strategy 3Reportlinker Adds Insulin Pumps (External) - A World Market Review 2Reportlinker Adds Insulin Pumps (External) - A World Market Review 3Reportlinker Adds Insulin Pumps (External) - A World Market Review 4China Medicine Announces Second Quarter 2009 Results 54412 1China Medicine Announces Second Quarter 2009 Results 54412 2China Medicine Announces Second Quarter 2009 Results 54412 3China Medicine Announces Second Quarter 2009 Results 54412 4China Medicine Announces Second Quarter 2009 Results 54412 5China Medicine Announces Second Quarter 2009 Results 54412 6China Medicine Announces Second Quarter 2009 Results 54412 7China Medicine Announces Second Quarter 2009 Results 54412 8China Medicine Announces Second Quarter 2009 Results 54412 9China Medicine Announces Second Quarter 2009 Results 54412 10China Medicine Announces Second Quarter 2009 Results 54412 11China Medicine Announces Second Quarter 2009 Results 54412 12China Medicine Announces Second Quarter 2009 Results 54412 13China Medicine Announces Second Quarter 2009 Results 54412 14Interventional Radiology Treatment for Uterine Fibroids 3A Safe Nonsurgical Option 54409 1Interventional Radiology Treatment for Uterine Fibroids 3A Safe Nonsurgical Option 54409 2Interventional Radiology Treatment for Uterine Fibroids 3A Safe Nonsurgical Option 54409 3Interventional Radiology Treatment for Uterine Fibroids 3A Safe Nonsurgical Option 54409 4Interventional Radiology Treatment for Uterine Fibroids 3A Safe Nonsurgical Option 54409 5Institute Chastises Congress on Health Care Reforms Offers Five Point Program for Reducing Health Care Costs by 50 25 54406 1Institute Chastises Congress on Health Care Reforms Offers Five Point Program for Reducing Health Care Costs by 50 25 54406 2
...ems Incorporated,(Nasdaq: IMCL ) and Bristol-Myer...t the U.S. Food and Drug Administration (FDA) has ...roduct labeling to include overall survival,data a...tor,(EGFR)-expressing metastatic colorectal cancer... and oxaliplatin-based regimens. The approval of ...
...tudies have suggested that,moderate red wine consu...,what if you,d like to skip the alcohol? Take hear...EALTH 2007 conference in Bordeaux, France,showed t...axation effect in,a similar fashion to red wine. T...rd grape juice induced a prolonged relaxation effe...
Other Medicine Technology:Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 2Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 3Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 4Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 5Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 6Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer 7New Study Shows Concord Grape Juice has a Heart-Healthy Effect not yet Reported With Red Wine 2
Penfield Dissector #1
Leroy Scalp Clips
Raney Scalp Clip System
Disposable Scalp Clip Applier
Medicine Products: